Skip to content
Welcome, thoughtbot's Giant Robots listeners!Start here
UK Startups and Innovation
22OCT

PhysicsX hits $2.4bn on Temasek cash

3 min read
16:30UTC

PhysicsX closed a $300m Series C at a $2.4bn valuation, the week's largest private round, led by Singapore's sovereign fund with no UK state vehicle on the cap table.

TechnologyDeveloping
Key takeaway

Singapore's Temasek led the week's largest UK round; no British state vehicle made the cap table.

PhysicsX, a London company founded in 2019 by former Formula 1 engineer Robin Tuluie and Jacomo Corbo, closed a $300m Series C on 8 June at a $2.4bn valuation, more than double its prior round⁠1. Singapore's sovereign fund Temasek led; M&G Investments and Intrepid Growth Partners came in new, with Atomico, Nvidia, Siemens, Applied Materials and General Catalyst following on.

PhysicsX builds AI that replaces the engineering simulations carmakers, aircraft makers and chip designers normally run over hours or days, collapsing them to seconds. It was the week's largest private round, and no UK state vehicle appears on the cap table. That absence has become the pattern. Orbital Industries pulled $50m a fortnight ago with no British lead either.

Britain's biggest rounds are now underwritten by Singapore, Silicon Valley and allied national-security funds, not by the £6.6bn the British Business Bank has to spend. The state development bank sits a tier below where the marquee rounds actually close, so the upside on the country's largest scale-ups accrues to foreign cap tables. A founder reading the cap table learns where the cheque that clears a nine-figure round actually comes from, and it is not Sheffield or London.

Deep Analysis

In plain English

Engineering simulations, running a car engine design through millions of virtual crash and heat tests, used to take a supercomputer hours. PhysicsX has built software that uses AI to do the same thing in seconds, which means engineers can test ten times more designs in the same day. Carmakers, aircraft builders and chip manufacturers all benefit. On 8 June, the company raised $300m, putting its total value at $2.4bn. The biggest cheque came from Temasek, Singapore's state investment fund. No UK government fund took part. Singapore's money is backing a British company because its AI tools connect directly to Asian manufacturing supply chains where Temasek already has investments. The UK's new British Business Bank mandate could theoretically have invested, but AI simulation for manufacturing is not in its priority sectors.

Deep Analysis
Root Causes

Three factors explain why Singapore's Temasek rather than any UK state vehicle led this round.

Temasek's investment thesis for PhysicsX sits in its advanced manufacturing vertical, where it holds positions in semiconductor capital equipment and automotive supply chains across Southeast Asia. PhysicsX's existing Siemens and Applied Materials customer relationships plug directly into that portfolio as a cross-sell tool, a strategic logic no UK sovereign fund had yet developed.

The British Business Bank's expanded mandate from April 2026 specifically authorised it to lead venture rounds up to £60m, but only in eight designated priority sectors. The eight sectors run from life sciences and clean energy to quantum and defence, and AI simulation for industrial applications falls outside every one of them. That sector exclusion left PhysicsX's round structurally outside what the BBB could lead.

The UK's Patient Capital Review of 2017, published by HM Treasury, identified the structural failure: UK institutional investors (insurance and pension funds) allocate under 1% of assets to venture capital versus 5-10% for US and Singaporean sovereign funds. M&G's entry as a new investor suggests the retail-and-pensions asset manager is finally moving toward the Patient Capital Review's recommendation, but M&G came in at a minority position, not as a lead.

What could happen next?
  • Risk

    Continued absence of UK state capital from deep-tech Series C rounds above £200m means equity upside from the most capital-intensive British innovations accrues offshore.

  • Opportunity

    M&G's new investor entry signals that a UK institutional investor is piloting direct venture positions; if the PhysicsX bet returns, it could catalyse broader insurance and pension fund movement toward UK deep-tech.

First Reported In

Update #8 · London startup raises Britain's own AI model

Bloomberg· 14 Jun 2026
Read original →
Different Perspectives
Abu Dhabi Investment Council
Abu Dhabi Investment Council
The Abu Dhabi Investment Council holds notes in Nscale's $3.36bn pre-IPO raise, beside Third Point, Apollo, Citadel and Nvidia. No British institution appears among the named holders of notes that convert into shares at Nscale's New York listing.
CDP Venture Capital
CDP Venture Capital
CDP Venture Capital, the venture arm of Italy's state lender, led TrueLayer's £20.4m round to expand Pay by Bank across Europe. A foreign state investor set the terms on a London fintech round in the same month the British Business Bank mostly followed.
EDBI
EDBI
Singapore's state investor EDBI joined Universal Quantum's Series A of more than $100m, and the Sussex company is opening its first research centre outside Europe in Singapore. British state money is absent from the largest Series A by a UK quantum company.
Forbion
Forbion
Forbion co-led OMass Therapeutics' $310m Series C with Bain Capital Life Sciences and Novo Holdings, while the British Business Bank and Syncona followed. The terms of the Oxford spinout's round were set by investors from three countries, none of them Britain.
British Business Bank
British Business Bank
The Bank committed £180m to six AI funds on 15 October with no UK-deployment condition, yet led the first close of Microbiotica's £36m Series C. That lead, with Airtel Money choosing London for its £5.3bn debut, is the evidence that British money and markets still set some terms.
Stryker Corporation
Stryker Corporation
Stryker called its roughly $400m CMR Surgical deal its entry into soft-tissue robotics, taking US sales rights for Versius, a board seat and an exclusive option over 100% of the company. The option lets Stryker choose whether and when a Cambridge robot maker becomes part of an American group.

Written with AI from Lowdown's published reporting. Not individually reviewed by an editor. Editorial standards.